Tab Application Banner
  • Users Online: 278
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
ORIGINAL ARTICLE
Ahead of Print

Autoantibodies in pediatric systemic lupus erythematosus: Cluster analysis and its clinical implications in Indian children


1 Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu, India
2 Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India
3 Department of Microbiology, Christian Medical College, Vellore, Tamil Nadu, India

Correspondence Address:
Sathish Kumar,
Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/injr.injr_129_21

Introduction: In children with Systemic Lupus Erythematosus (SLE), autoantibodies are considered as biomarkers for specific organ involvement or tissue damage. Some autoantibodies are used for diagnosis, disease activity, and few for disease characterisation. By using cluster analysis, we identified antibody clustering in children with SLE with specific subsets of clinical manifestations at the time of diagnosis. Materials and Methods: All pediatric SLE (pSLE) who fulfilled 4/11 ACR criteria were included in this study. Their autoantibodies profiles were noted. We recruited 212 patients with newly diagnosed pSLE and cluster analysis was done. We identified 3 clusters which were used for analysis. Results: Cluster 1 had ANA and anti-dsDNA antibodies a low prevalence of all other antibodies. Children in cluster 2 had autoantibodies such as ANA, anti-dsDNA, anti-RNP, and anti-Sm. Cluster 3 was had autoantibodies such as dsDNA, ANA, anti-cardiolipin and anti-SSA antibodies. On analysis, there was statistically significant difference among the 3 clusters for hair loss (P = 0.006), oral ulcers (P = 0.024), arthritis (P = 0.025), neurological symptoms (P = 0.037), renal manifestations (P = 0.003), AIHA (P = 0.012). Conclusion: In pSLE, autoantibodies clusters with distinct clinical phenotypes. Hence, all autoantibodies should be done at time of diagnosis. It will help in predicting the clinical course of pSLE and also to identify patients at risk of developing major organ involvement later.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Vyasam S
    -  Punnen A
    -  Jeyaseelan V
    -  Prakash JJ
    -  Kumar S
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed81    
    PDF Downloaded4    

Recommend this journal